{"nct_id":"NCT03474965","title":"Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2018-10-01","start_date_type":"ACTUAL","primary_completion_date":"2024-11-06","primary_completion_date_type":"ACTUAL","completion_date":"2024-11-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}